Vγ1 γδ T cells steer airway macrophages toward a profibrotic response in an autochthonous lung cancer mouse model.
Summary
In an autochthonous lung cancer mouse model, tumors expand specific γδ T cell subsets, with Vγ1 γδ T cells directing airway macrophages toward a profibrotic state. This reveals a γδ T cell–macrophage axis that can promote tumor-associated fibrosis and reshape the tumor microenvironment.
Key Findings
- Tumors in a genetically engineered mouse model expand γδ T cell subsets, including Vγ1 cells.
- Vγ1 γδ T cells skew airway macrophages toward a profibrotic phenotype within the tumor microenvironment.
- Findings define a γδ T cell–macrophage axis linking tumor growth to fibrotic remodeling.
Clinical Implications
Targeting Vγ1 γδ T cell–macrophage crosstalk or downstream profibrotic programs may mitigate tumor-associated fibrosis and improve response to therapy in lung cancer.
Why It Matters
This mechanistic work uncovers a previously unappreciated γδ T cell–driven programming of airway macrophages toward fibrosis in lung cancer, suggesting new immuno-fibrotic targets.
Limitations
- Preclinical murine findings require validation in human tissues and across tumor subtypes.
- Therapeutic modulation of the identified axis was not tested in interventional studies.
Future Directions
Validate γδ T cell–macrophage pathways in human lung cancer, define molecular mediators of profibrotic programming, and test targeted interventions to disrupt this axis.
Study Information
- Study Type
- Basic/Mechanistic Research
- Research Domain
- Pathophysiology
- Evidence Level
- V - Preclinical mechanistic study in a genetically engineered mouse model
- Study Design
- OTHER